Improving access to opioid treatment for disabled Medicare beneficiaries
Improving MOUD Access, Opioid-Related Outcomes and Equity Among Medicare Beneficiaries with Disability
This study is looking at ways to make it easier for people with disabilities on Medicare to get the medications they need for opioid use disorder, so they can start and stick with their treatment and ultimately improve their health and reduce overdoses.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-10857254 on NIH RePORTER |
What this research studies
This research investigates how to enhance access to medications for opioid use disorder (MOUD) among Medicare beneficiaries with disabilities. It aims to understand the factors that affect the initiation and retention of treatment, particularly focusing on disparities faced by this population. By analyzing national Medicare data alongside other relevant data sources, the study will explore the impact of policies, community resources, and patient characteristics on treatment outcomes. The goal is to identify effective strategies to reduce opioid overdoses and improve overall health outcomes for these individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research are Medicare beneficiaries with disabilities who are at risk for opioid use disorder or have experienced opioid overdoses.
Not a fit: Patients who do not have Medicare or do not have disabilities may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved access to effective opioid treatment for disabled Medicare beneficiaries, ultimately reducing overdose rates and enhancing their quality of life.
How similar studies have performed: Previous research has shown that addressing systemic barriers in healthcare can improve treatment access and outcomes for marginalized populations, suggesting that this approach may yield positive results.
Where this research is happening
Newark, UNITED STATES
- Rutgers Biomedical and Health Sciences — Newark, United States (Active)
Researchers
- Principal investigator: Crystal, Stephen — Rutgers Biomedical and Health Sciences
- Study coordinator: Crystal, Stephen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.